HEADER COMPLEX (TRANSFERASE/CYCLIN/INHIBITOR) 03-JUL-96 1JSU TITLE P27(KIP1)/CYCLIN A/CDK2 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE-2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CDK2; COMPND 5 EC: 2.7.1.-; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CYCLIN A; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: RESIDUES 173 - 432; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: P27; COMPND 15 CHAIN: C; COMPND 16 FRAGMENT: RESIDUES 22 - 106; COMPND 17 SYNONYM: KIP1, CIP2; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: SF9; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET3A; SOURCE 12 OTHER_DETAILS: CYCLIN A-BOUND FORM PHOSPHORYLATED ON THR SOURCE 13 160 IN VITRO USING A CDK-ACTIVATING KINASE CONSISTING OF SOURCE 14 THE CYCLINH-CDK7 COMPLEX; SOURCE 15 MOL_ID: 2; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 CELL_LINE: SF9; SOURCE 20 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 22 EXPRESSION_SYSTEM_PLASMID: PET3A; SOURCE 23 OTHER_DETAILS: THE FRAGMENT USED IN THE CRYSTALLIZATION SOURCE 24 WAS PRODUCED BY THE CLEAVAGE OF FULL-LENGTH CYCLIN A BY SOURCE 25 SUBTILISIN; SOURCE 26 MOL_ID: 3; SOURCE 27 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 28 ORGANISM_COMMON: HUMAN; SOURCE 29 ORGANISM_TAXID: 9606; SOURCE 30 CELL_LINE: SF9; SOURCE 31 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 32 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 33 EXPRESSION_SYSTEM_PLASMID: PET3A KEYWDS COMPLEX (TRANSFERASE/CYCLIN/INHIBITOR), KINASE, CELL CYCLE, KEYWDS 2 CELL DIVISION, CDK, CYCLIN, INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR A.A.RUSSO,P.D.JEFFREY,N.P.PAVLETICH REVDAT 2 24-FEB-09 1JSU 1 VERSN REVDAT 1 29-JUL-97 1JSU 0 JRNL AUTH A.A.RUSSO,P.D.JEFFREY,A.K.PATTEN,J.MASSAGUE, JRNL AUTH 2 N.P.PAVLETICH JRNL TITL CRYSTAL STRUCTURE OF THE P27KIP1 JRNL TITL 2 CYCLIN-DEPENDENT-KINASE INHIBITOR BOUND TO THE JRNL TITL 3 CYCLIN A-CDK2 COMPLEX. JRNL REF NATURE V. 382 325 1996 JRNL REFN ISSN 0028-0836 JRNL PMID 8684460 JRNL DOI 10.1038/382325A0 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 7.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 3 NUMBER OF REFLECTIONS : 31351 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4980 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 5 REMARK 3 SOLVENT ATOMS : 197 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.012 ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : 1.450 ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : 3.600 ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : NULL REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1JSU COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-FEB-96 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 162339 REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.12 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.90000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 68.60000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.15000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 68.60000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.90000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.15000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9210 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24400 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -61.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 ASN A 3 REMARK 465 PHE A 4 REMARK 465 GLN A 5 REMARK 465 LYS A 6 REMARK 465 VAL A 7 REMARK 465 GLU A 8 REMARK 465 LYS A 9 REMARK 465 ILE A 10 REMARK 465 GLY A 11 REMARK 465 GLU A 12 REMARK 465 ASN B 173 REMARK 465 GLU B 174 REMARK 465 HIS C 23 REMARK 465 PRO C 24 REMARK 465 PRO C 94 REMARK 465 PRO C 95 REMARK 465 LYS C 96 REMARK 465 GLY C 97 REMARK 465 ALA C 98 REMARK 465 CYS C 99 REMARK 465 LYS C 100 REMARK 465 VAL C 101 REMARK 465 PRO C 102 REMARK 465 ALA C 103 REMARK 465 GLN C 104 REMARK 465 GLU C 105 REMARK 465 SER C 106 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 14 114.30 66.95 REMARK 500 ASN A 23 -102.56 -119.76 REMARK 500 LYS A 24 -162.17 -174.92 REMARK 500 LEU A 25 -162.68 64.06 REMARK 500 GLU A 42 -53.39 79.19 REMARK 500 ASN A 74 12.37 -146.76 REMARK 500 ASP A 127 53.29 -155.05 REMARK 500 ASP A 145 89.08 63.39 REMARK 500 VAL A 164 131.57 74.10 REMARK 500 SER A 181 -155.35 -144.32 REMARK 500 CYS B 193 29.29 -76.92 REMARK 500 PHE B 304 11.02 57.96 REMARK 500 LEU B 320 5.63 -64.57 REMARK 500 GLN B 323 73.00 -118.00 REMARK 500 TRP B 372 114.93 -38.64 REMARK 500 MET C 52 84.65 -66.91 REMARK 500 GLU C 53 -64.13 -155.92 REMARK 500 GLU C 54 -105.01 -11.78 REMARK 500 LEU C 70 -161.25 -166.34 REMARK 500 GLU C 71 -106.52 33.98 REMARK 500 LYS C 73 -31.77 134.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 299 DBREF 1JSU A 1 298 UNP P24941 CDK2_HUMAN 1 298 DBREF 1JSU B 173 432 UNP P20248 CCNA2_HUMAN 173 432 DBREF 1JSU C 23 106 UNP P46527 CDN1B_HUMAN 23 106 SEQADV 1JSU TPO A 160 UNP P24941 THR 160 MODIFIED RESIDUE SEQRES 1 A 298 MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY GLU GLY SEQRES 2 A 298 THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS LEU THR SEQRES 3 A 298 GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU ASP THR SEQRES 4 A 298 GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG GLU ILE SEQRES 5 A 298 SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE VAL LYS SEQRES 6 A 298 LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU TYR LEU SEQRES 7 A 298 VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS PHE MET SEQRES 8 A 298 ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO LEU ILE SEQRES 9 A 298 LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU ALA PHE SEQRES 10 A 298 CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU LYS PRO SEQRES 11 A 298 GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE LYS LEU SEQRES 12 A 298 ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL PRO VAL SEQRES 13 A 298 ARG THR TYR TPO HIS GLU VAL VAL THR LEU TRP TYR ARG SEQRES 14 A 298 ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SER THR SEQRES 15 A 298 ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE ALA GLU SEQRES 16 A 298 MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SER GLU SEQRES 17 A 298 ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU GLY THR SEQRES 18 A 298 PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER MET PRO SEQRES 19 A 298 ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG GLN ASP SEQRES 20 A 298 PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP GLY ARG SEQRES 21 A 298 SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO ASN LYS SEQRES 22 A 298 ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO PHE PHE SEQRES 23 A 298 GLN ASP VAL THR LYS PRO VAL PRO HIS LEU ARG LEU SEQRES 1 B 260 ASN GLU VAL PRO ASP TYR HIS GLU ASP ILE HIS THR TYR SEQRES 2 B 260 LEU ARG GLU MET GLU VAL LYS CYS LYS PRO LYS VAL GLY SEQRES 3 B 260 TYR MET LYS LYS GLN PRO ASP ILE THR ASN SER MET ARG SEQRES 4 B 260 ALA ILE LEU VAL ASP TRP LEU VAL GLU VAL GLY GLU GLU SEQRES 5 B 260 TYR LYS LEU GLN ASN GLU THR LEU HIS LEU ALA VAL ASN SEQRES 6 B 260 TYR ILE ASP ARG PHE LEU SER SER MET SER VAL LEU ARG SEQRES 7 B 260 GLY LYS LEU GLN LEU VAL GLY THR ALA ALA MET LEU LEU SEQRES 8 B 260 ALA SER LYS PHE GLU GLU ILE TYR PRO PRO GLU VAL ALA SEQRES 9 B 260 GLU PHE VAL TYR ILE THR ASP ASP THR TYR THR LYS LYS SEQRES 10 B 260 GLN VAL LEU ARG MET GLU HIS LEU VAL LEU LYS VAL LEU SEQRES 11 B 260 THR PHE ASP LEU ALA ALA PRO THR VAL ASN GLN PHE LEU SEQRES 12 B 260 THR GLN TYR PHE LEU HIS GLN GLN PRO ALA ASN CYS LYS SEQRES 13 B 260 VAL GLU SER LEU ALA MET PHE LEU GLY GLU LEU SER LEU SEQRES 14 B 260 ILE ASP ALA ASP PRO TYR LEU LYS TYR LEU PRO SER VAL SEQRES 15 B 260 ILE ALA GLY ALA ALA PHE HIS LEU ALA LEU TYR THR VAL SEQRES 16 B 260 THR GLY GLN SER TRP PRO GLU SER LEU ILE ARG LYS THR SEQRES 17 B 260 GLY TYR THR LEU GLU SER LEU LYS PRO CYS LEU MET ASP SEQRES 18 B 260 LEU HIS GLN THR TYR LEU LYS ALA PRO GLN HIS ALA GLN SEQRES 19 B 260 GLN SER ILE ARG GLU LYS TYR LYS ASN SER LYS TYR HIS SEQRES 20 B 260 GLY VAL SER LEU LEU ASN PRO PRO GLU THR LEU ASN LEU SEQRES 1 C 84 HIS PRO LYS PRO SER ALA CYS ARG ASN LEU PHE GLY PRO SEQRES 2 C 84 VAL ASP HIS GLU GLU LEU THR ARG ASP LEU GLU LYS HIS SEQRES 3 C 84 CYS ARG ASP MET GLU GLU ALA SER GLN ARG LYS TRP ASN SEQRES 4 C 84 PHE ASP PHE GLN ASN HIS LYS PRO LEU GLU GLY LYS TYR SEQRES 5 C 84 GLU TRP GLN GLU VAL GLU LYS GLY SER LEU PRO GLU PHE SEQRES 6 C 84 TYR TYR ARG PRO PRO ARG PRO PRO LYS GLY ALA CYS LYS SEQRES 7 C 84 VAL PRO ALA GLN GLU SER MODRES 1JSU TPO A 160 THR PHOSPHOTHREONINE HET TPO A 160 11 HET SO4 A 299 5 HETNAM TPO PHOSPHOTHREONINE HETNAM SO4 SULFATE ION HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO C4 H10 N O6 P FORMUL 4 SO4 O4 S 2- FORMUL 5 HOH *197(H2 O) HELIX 1 1 SER A 46 GLU A 57 1 12 HELIX 2 2 LEU A 87 ALA A 93 1 7 HELIX 3 3 LEU A 101 HIS A 121 1 21 HELIX 4 4 PRO A 130 ASN A 132 5 3 HELIX 5 5 LEU A 166 TYR A 168 5 3 HELIX 6 6 PRO A 171 LEU A 174 1 4 HELIX 7 7 THR A 182 THR A 198 5 17 HELIX 8 8 GLU A 208 LEU A 219 1 12 HELIX 9 9 VAL A 230 SER A 232 5 3 HELIX 10 10 PHE A 248 VAL A 251 1 4 HELIX 11 11 GLU A 257 MET A 266 1 10 HELIX 12 12 ALA A 277 ALA A 282 1 6 HELIX 13 13 PRO A 284 ASP A 288 5 5 HELIX 14 14 HIS B 179 LYS B 192 1 14 HELIX 15 15 TYR B 199 LYS B 202 5 4 HELIX 16 16 ASN B 208 GLU B 224 1 17 HELIX 17 17 ASN B 229 LEU B 243 1 15 HELIX 18 18 ARG B 250 GLU B 268 1 19 HELIX 19 19 VAL B 275 THR B 282 1 8 HELIX 20 20 LYS B 288 VAL B 301 1 14 HELIX 21 21 VAL B 311 HIS B 321 1 11 HELIX 22 22 CYS B 327 ILE B 342 1 16 HELIX 23 23 ALA B 344 LYS B 349 1 6 HELIX 24 24 PRO B 352 THR B 368 1 17 HELIX 25 25 GLU B 374 THR B 380 1 7 HELIX 26 26 LEU B 384 GLN B 403 1 20 HELIX 27 27 SER B 408 LYS B 414 1 7 HELIX 28 28 SER B 416 TYR B 418 5 3 HELIX 29 29 VAL B 421 LEU B 423 5 3 HELIX 30 30 HIS C 38 ARG C 50 1 13 HELIX 31 31 GLU C 54 LYS C 59 1 6 HELIX 32 32 LYS C 81 SER C 83 5 3 HELIX 33 33 GLU C 86 TYR C 89 5 4 SHEET 1 A 5 GLU C 75 GLU C 80 0 SHEET 2 A 5 VAL A 17 ARG A 22 -1 N ARG A 22 O GLU C 75 SHEET 3 A 5 VAL A 29 ARG A 36 -1 N VAL A 30 O ALA A 21 SHEET 4 A 5 LYS A 75 GLU A 81 -1 N PHE A 80 O ALA A 31 SHEET 5 A 5 LEU A 66 HIS A 71 -1 N ILE A 70 O TYR A 77 SHEET 1 B 2 LEU A 133 ILE A 135 0 SHEET 2 B 2 ILE A 141 LEU A 143 -1 N LYS A 142 O LEU A 134 LINK N TPO A 160 C TYR A 159 1555 1555 1.33 LINK C TPO A 160 N HIS A 161 1555 1555 1.32 CISPEP 1 VAL A 154 PRO A 155 0 0.01 CISPEP 2 GLN B 323 PRO B 324 0 -0.16 CISPEP 3 ASP B 345 PRO B 346 0 0.59 CISPEP 4 LYS C 25 PRO C 26 0 -0.35 SITE 1 AC1 5 ARG A 214 ARG A 217 LYS A 278 HOH A 318 SITE 2 AC1 5 HOH A 384 CRYST1 73.800 78.300 137.200 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013550 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012771 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007289 0.00000